Research ArticleConference Proceedings
Proceedings of the 2023 Viral Clearance Symposium, Session 7: Up- and Downstream Virus Retentive Filtration
Xiaoxiang Zhu and Sean O’Donnell
PDA Journal of Pharmaceutical Science and Technology March 2024, 78 (2) 196-205; DOI: https://doi.org/10.5731/pdajpst.2024.002247
Xiaoxiang Zhu
1Pivotal Drug Substance Biologics, Process Development, Amgen Inc., 360 Binney Street, Cambridge, MA 02138; and
Sean O’Donnell
2BioProcess Research and Development, Eli Lilly and Co., Lilly Corporate Center, Indianapolis, IN 46285

References
- 1.↵
- Wieser A.,
- Modrof J.,
- Kreil T. R.
- 2.↵Parenteral Drug Association Inc. Technical Report No. 41 Revised: Virus Filtration; Bethesda, MD, 2022.
- 3.↵
- 4.↵
- Garnick R. L.
- 5.↵
- Nims R. W.
- 6.↵The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit, CPMP Biotechnology Working Party. Note for Guidance on Virus Validation Studies: The Design, Contribution, and Interpretation of Studies Validating the Inactivation and Removal of Viruses; EMEA/CPMP/BWP/268/95; London, 1996.
- 7.↵
- Wieser A.,
- Berting A.,
- Medek C.,
- Poelsler G.,
- Kreil T. R.
- 8.↵
- Opeyemi O. A.,
- Johnson S. A.,
- Faison T.,
- Azer N.,
- Cullinan J. L.,
- Dement‐Brown J.,
- Lute S. C.
- 9.↵
- Yamamoto A.,
- Hongo-Hirasaki T.,
- Uchi Y.,
- Hayashida H.,
- Nagoya F.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 78, Issue 2
March/April 2024
Proceedings of the 2023 Viral Clearance Symposium, Session 7: Up- and Downstream Virus Retentive Filtration
Xiaoxiang Zhu, Sean O’Donnell
PDA Journal of Pharmaceutical Science and Technology Mar 2024, 78 (2) 196-205; DOI: 10.5731/pdajpst.2024.002247
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.